Life science tools and diagnostics innovator joins top-tier global cohort competing for $300,000 in cash prizes
Boulder, CO – Aridica Corporation is pleased to announce its selection for the 2025 BioTools Innovator Accelerator, the first and only program focused exclusively on life science tools and diagnostics companies. Chosen from over 400 applicants, Aridica Corporation is among just 31 startups to earn a spot in this year’s prestigious cohort.
BioTools Innovator provides a four-month accelerator program offering tailored mentorship from senior industry leaders, investor exposure, and networking opportunities with peers and experts across the global life science community. At the end of the program, companies will compete for $300,000 in non-dilutive cash prizes.
“We are honored to be recognized among the most promising innovators in life science tools and diagnostics,” said Palani Palaniappan, CEO of Aridica. “This opportunity will help us accelerate the development and commercialization of our PBMC separation platform. We’re excited to engage with industry mentors and connect with peers as part of the BioTools Innovator ecosystem.”
Aridica Corporation was also selected to participate in the VANGUARD Accelerator, a joint initiative with BARDA to support companies advancing medical countermeasures for public health emergencies. VANGUARD is a joint initiative between BioTools Innovator and the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services, to support startups in deploying innovative medical countermeasures that enhance the U.S.’ readiness for public health emergencies.*
As part of the BioTools Innovator 2025 program, Aridica Corporation will participate in a series of events, including the Innovator Summit (June 24–26 in Mountain View, CA), pitch opportunities, and a final Capstone Event where companies will compete for a share of $300,000 in non-dilutive funding.
*This project has been supported in whole or in part with federal funds from the U.S. Department of Health and Human Services; Administration for Strategic Preparedness and Response; Biomedical Advanced Research and Development Authority (BARDA), under agreement number 75A50124C00034.
About BioTools Innovator
BioTools Innovator, based in Los Angeles, advances cutting-edge research and improves human health by accelerating the growth of life science tools and diagnostics startups. Powered by MedTech Innovator, the world’s largest accelerator for medical technology companies, BTI supports early-stage and emerging growth companies through mentorship, visibility, and non-dilutive funding opportunities. Learn more at https://biotoolsinnovator.org.
For more information on BTI and the 2025 Cohort and BTI, click here.